Application form: tablets, capsules
Indication group: expectorants, mucolytics
Active substance: Ambroxoli hydrochloridum 30mg v 1 tbl
minimum amount for dispatch: Ambrobene is expectorant with a mucolytic effect, causes an increased production of phlegm and at the same time dilutes phlegm, facilitates the movement of cilia and thus cleans the airways mucosa and increases its resistance against infection. Ambrobene is indicated for the treatment of acute and chronic diseases of airways connected with difficult expectoration, for the treatment of infectious diseases of airways, and acute and chronic inflammation of paranasal sinuses. It is possible to administer Ambrobene both to children and adults.
Manufacturer: Merckle/ratiopharm Gmbh, Blaubeuren, Germany